It has been observed that Eculizumab, a humanized monoclonal antibody impedes the cleavage of C5 to C5a and C5b plunged the NETosis in patients with paroxysmal nocturnal hemoglobinuria (PNH) [53]. This evidence concerns the gene C5AR1 and paroxysmal nocturnal hemoglobinuria.